How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update.

ABSTRACT: Nowadays, the management of prostate cancer has become more and more challenging due to the increasing number of available treatment options, therapeutic agents, and our understanding of its carcinogenesis and disease progression. Moreover, currently available risk stratification systems used to facilitate clinical decision-making have limitations, particularly in providing a personalized and patient-centered management strategy. Although prognosis and prostate cancer-specific survival have improved in recent years, the heterogenous behavior of the disease among patients included in the same risk prognostic group negatively impacts not only our clinical decision-making but also oncological outcomes, irrespective of the treatment strategy. Several biomarkers, along with available tests, hav

SUBMITTER: Baston C 

PROVIDER: S-EPMC10813985 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature